Asthma exacerbations during the pandemic: Time to rethink clinical markers

BACKGROUND: Reductions in asthma exacerbations during the coronavirus disease 2019 (COVID-19) pandemic may have an impact on clinical trial enrollment and outcomes. OBJECTIVE: Our aim was to review clinical studies and reports evaluating asthma exacerbations before and during the COVID-19 pandemic....

Descripción completa

Detalles Bibliográficos
Autores principales: Ortega, Hector, Katz, Lynn Eva, Chupp, Geoffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581642/
https://www.ncbi.nlm.nih.gov/pubmed/36281240
http://dx.doi.org/10.1016/j.jacig.2022.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581642/
https://www.ncbi.nlm.nih.gov/pubmed/36281240
http://dx.doi.org/10.1016/j.jacig.2022.09.003

Ejemplares similares